HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 518101Generated: November 1, 2026
1-Chloroethyl chloroformate → 3-Cyclopropyl-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine hydrochloride
https://huagongshe.com/reaction/518101
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Chloroethyl chloroformate | HCID 521305 | — |
| Reactant | 8-Benzyl-3-cyclopropyl-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine | HCID 66993315 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 3-Cyclopropyl-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine hydrochloride | HCID 66993444 | 16% |
Reaction Steps
To a solution of 8-benzyl-3-cyclopropyl-6,7,8,9-tetrahydropyrazino[2,3-f][1,4]oxazepine (79.9 mg) in toluene (3 mL) was added 1-chloroethyl chloroformate (0.033 mL), and the mixture was stirred at 100° C. for 3 hr. The reaction mixture was cooled to room temperature, and concentrated. To the obtained residue was added methanol (3 mL) and the mixture was stirred at 60° C. for 2 hr. The reaction mixture was cooled to room temperature, and concentrated. The concentrate was diluted with ethyl acetate, and washed with saturated aqueous sodium hydrogen carbonate, water and saturated brine. The organic layer was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The obtained residue was purified by basic silica gel column chromatography (solvent gradient; 10→100% ethyl acetate/hexane). To a solution of the obtained oil in methanol (1 mL) was added 0.1 N hydrochloric acid (0.6 mL), and the mixture was concentrated under reduced pressure. The obtained crude crystals were purified by recrystallization (ethanol-diisopropyl ether) to give the title compound (10.2 mg, 16%) as colorless crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09115139B2 |
|---|
| Source dataset | uspto-grants-2015_08 |
|---|
| ORD ID | ord-187fca072f8b4d539bc89998fd3f953d |
|---|
| Source note | uspto-grants-2015_08 |
|---|